原钙黏蛋白在人恶性肿瘤中的异常表达及功能被引量：2

Abnormal expression and functions of proto-cadherins in human malignant tumor

导出

摘要原钙黏蛋白(protocadherins,PCDHs)是属于钙黏蛋白超家族中的一组跨膜蛋白,分为集群型和非集群型两种。前期研究表明PCDHs能调节脑的发育并和一些神经疾病的发生相关。最近的研究表明在不同的人恶性肿瘤细胞中PCDHs均有异常表达。恶性肿瘤中PCDHs的表达下调或者缺失与癌症进展有关。另有研究证实PCDHs可能作为肿瘤抑制剂抑制癌症细胞的增殖和转移。对PCDHs在癌症中表达变化及其在癌症进程发展中的作用进行总结有利于探讨PCDHs异常表达及其调节癌症潜在的机制。 Proto-cadherins (PCDHs)are a class of cadherin-like membrane proteins which can be divided into clustered PCDHs and non-clustered PCDHs.Previous research showed that proto-cadherins can regulate the development of neurons and play a role in the maturation of brain.Lately,some abnormal expressions of PCDHs have been identified in different human malignant tumors.The reduction or deficiency of PCDHs in malignant cells has certain links with cancer progression.A follow-up study suggests that PCDHs can be a tumor suppressor since these proteins inhibit the proliferation and metastasis of cancer cell.The aim of this review is to evaluate the altered expression of PCDHs and their actions during the development of cancer.

作者侯斯琦乔娟娟徐争研张磊 Hou Siqi;Qiao Juanjuan;Xu Zhengyan;Zhang Lei(partment of Pathology,Harbin Medical University,Harbin 150081,China)

机构地区哈尔滨医科大学生理学与病理学教研室

出处《国际免疫学杂志》 CAS 2019年第1期109-112,共4页 International Journal of Immunology

关键词原钙黏蛋白恶性肿瘤肿瘤抑制剂 Protocadherin Malignant tumor Tumor inhibitor

分类号 R730.2 [医药卫生—肿瘤]

引文网络
相关文献

参考文献2

1李葛,韩根成.Tim-3与肿瘤免疫的研究进展[J].国际免疫学杂志,2016,39(3):241-244. 被引量：5
2杨智祺,单风平.新型免疫指标与疾病诊疗的研究进展[J].国际免疫学杂志,2017,40(5):580-583. 被引量：2

二级参考文献20

1Mclntire JJ, Umetsus SE,Akbari 0,et al. Identification of Tapr( anairway hyperreactivity regulatory locus) and the linked Tim genefamily[ J]. Nat Immunol ,2001, 2 (12 ) : 1109-1116.
2Sakuishi K, Jayaraman P, Behar SM,et al. Emerging Tim-3 func-tions in anti-microbial and tumor immunity[ J]. Trends Immunol,2011,32:345-349.
3Sabatos CA,Chakravarti S,Cha E,et al. Interaction of Tim-3 andTim-3 ligand regulates T helper type I responses and induction ofperipheral tolerance [ J]. Nat Immunol,2003 ,4(11) :1102-1110.
4uchroo VK,Umet su DT,Dekruyff RH,et al. The TIM gene family :emerging roles in immunity and disease [ J ]. Nat Rev Immunol,2003,3:454-462.
5Freeman GJ,Casasnovas JM,Umetsu DT,et al. TIM genes: a fami-ly of cell surface phosphatidylserine receptors that regulate innateand adaptive immunity [ J ]. Immunol Rev,2010,235 ( 1 ) : 172-189.
6Chiba S,Baghdadi M, Akiba H,et al. Tumor-infiltrating DCs sup-press nucleic acid-mediated innate immune responses through in-teractions between the receptor TIM-3 and the alarmin HMGB1[J].Nat Immunol, 2012,13 (9 ) : 832-842.
7Jiang J, Jin MS, Kong F, et al. Decreased Galectin-9 and In-creased Tim-3 Expression Are Related to Poor Prognosis in Gas-tric Cancer [ J]. PLoS One, 2013, 8 (12 ) : e81799.
8Piao YR, Jin ZH, Yuan KC, et al. Analysis of Tim-3 as a thera-peutic target in prostate cancer [J] . Tumour Biol,2014,35( 11 ):11409-11414.
9Gao X,Zhu Y,Li G,et al. TIM-3 Expression Characterizes Regu-latory T Cells in Tumor Tissues and is Associated with LungCancer Progression[ J]. PLOS One,2012,7 (2) :332-337.
10Zhou Q, Munger ME, Veenstra RG,et al. Coexpression of Tim-3and PD-1 identifies a CD8 + T-cell exhaustion phenotype in micewith disseminated acute myelogenous leukemiaf J]. Blood ,2011,117( 17) :4501-4510.